
This square weight-loss ad template is built for a digital medical weight-management service offering GLP‑1 support with a stronger long‑term plan. The design uses a bold coral-to-blush gradient backg...
Free — No credit card required
This square weight-loss ad template is built for a digital medical weight-management service offering GLP‑1 support with a stronger long‑term plan. The design uses a bold coral-to-blush gradient background, oversized black serif headline text, and multiple white strike-through lines that visually “correct” the statement “Weight loss medication doesn’t work long term.” That pattern instantly creates curiosity and positions the brand as an authority willing to challenge a common belief. A secondary claim block highlights “3x more weight” in a red callout, while a realistic injection pen at the lower right anchors the concept of injectable medication without showing a person. The CTA line “SEE IF YOU QUALIFY” sits prominently near the bottom, signaling a consideration-stage next step and pre-qualifying intent. This layout works well for solution-aware audiences comparing GLP‑1 options: it blends efficacy framing with compliance-friendly disclaimers space. Customize by swapping the claim ratio, adding your clinic’s name, updating the pen color to match brand guidelines, and replacing the qualifier CTA with your own eligibility quiz or consult booking.
The creative wins by combining curiosity and authority: the large, strike-through headline visually signals a “myth correction,” prompting readers to pause and re-evaluate what they believe about long-term weight-loss medication. That disruption is ideal for solution-aware users who know GLP‑1s but are unsure about durability. The quantified “3x” callout adds an efficacy anchor while keeping the rest of the message clean and scannable. Placing an injectable pen image reinforces category clarity without relying on body imagery, which can reduce trust or trigger sensitivity. The CTA “See if you qualify” matches a mid-funnel consideration moment—users aren’t being asked to buy immediately, but to take a low-commitment eligibility step, pre-qualifying leads for a regulated service. Fine-print space supports best practices for medical claims and reduces perceived risk.
Adults exploring prescription weight-loss options who are already aware of GLP‑1 medications and are comparing programs, clinics, or telehealth providers. They respond to evidence-led claims, want reassurance about long-term results, and prefer a low-friction next step like an eligibility check before committing.
Free — No credit card required